AdAlta

A biotech company that develops and commercialises protein-based therapeutics
AdAlta
Operating

AdAlta is the pioneer of a novel technology platform that mimics the shape and engineers key stability features of the antigen binding domain of shark antibodies into human proteins to create unique compounds, known as i-bodies, for therapeutic intervention in disease. AdAlta is utilising the power of its i-body technology platform to develop a pipeline of i-bodies (drugs), with an initial focus on treating fibrotic diseases.

Investors
Investor

Brisbane Angels

Investor

Yuuwa Capital

Accelerators
2013
Accelerator

SBE Australia

Images
Taken on 2017-12
 Location
Melbourne
 Links
 People
 Tags
#biotech
#health
#wellness
 Feedback